| 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents R Ottana, R Maccari, ML Barreca, G Bruno, A Rotondo, A Rossi, ... Bioorganic & medicinal chemistry 13 (13), 4243-4252, 2005 | 436 | 2005 |
| Synthesis and aldose reductase inhibitory activity of 5-arylidene-2, 4-thiazolidinediones G Bruno, L Costantino, C Curinga, R Maccari, F Monforte, F Nicolò, ... Bioorganic & medicinal chemistry 10 (4), 1077-1084, 2002 | 313 | 2002 |
| Synthesis and antiinflammatory, analgesic activity of 3, 3′-(1, 2-Ethanediyl)-bis [2-aryl-4-thiazolidinone] chiral compounds. Part 10 MG Vigorita, R Ottana, F Monforte, R Maccari, A Trovato, MT Monforte, ... Bioorganic & Medicinal Chemistry Letters 11 (21), 2791-2794, 2001 | 227 | 2001 |
| In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I R Ottanà, S Carotti, R Maccari, I Landini, G Chiricosta, B Caciagli, ... Bioorganic & medicinal chemistry letters 15 (17), 3930-3933, 2005 | 208 | 2005 |
| In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 R Maccari, R Ottana, MG Vigorita Bioorganic & medicinal chemistry letters 15 (10), 2509-2513, 2005 | 204 | 2005 |
| Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions R Maccari, R Ottanà Journal of medicinal chemistry 58 (5), 2047-2067, 2015 | 175 | 2015 |
| Structure–activity relationships and molecular modelling of 5-arylidene-2, 4-thiazolidinediones active as aldose reductase inhibitors R Maccari, R Ottanà, C Curinga, MG Vigorita, D Rakowitz, T Steindl, ... Bioorganic & medicinal chemistry 13 (8), 2809-2823, 2005 | 142 | 2005 |
| 5-Arylidene-2, 4-thiazolidinediones as inhibitors of protein tyrosine phosphatases R Maccari, P Paoli, R Ottanà, M Jacomelli, R Ciurleo, G Manao, T Steindl, ... Bioorganic & medicinal chemistry 15 (15), 5137-5149, 2007 | 136 | 2007 |
| Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic … R Ottanà, R Maccari, M Giglio, A Del Corso, M Cappiello, U Mura, ... European journal of medicinal chemistry 46 (7), 2797-2806, 2011 | 133 | 2011 |
| Isoniazid-related copper (II) and nickel (II) complexes with antimycobacterial in vitro activity. Part 9 B Bottari, R Maccari, F Monforte, R Ottana, E Rotondo, MG Vigorita Bioorganic & medicinal chemistry letters 10 (7), 657-660, 2000 | 130 | 2000 |
| 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors R Ottanà, R Maccari, R Ciurleo, P Paoli, M Jacomelli, G Manao, G Camici, ... Bioorganic & medicinal chemistry 17 (5), 1928-1937, 2009 | 107 | 2009 |
| Modeling and biological evaluation of 3, 3′-(1, 2-ethanediyl) bis [2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor R Ottaná, E Mazzon, L Dugo, F Monforte, R Maccari, L Sautebin, ... European journal of pharmacology 448 (1), 71-80, 2002 | 105 | 2002 |
| In vitro aldose reductase inhibitory activity of 5-benzyl-2, 4-thiazolidinediones D Rakowitz, R Maccari, R Ottanà, MG Vigorita Bioorganic & medicinal chemistry 14 (2), 567-574, 2006 | 100 | 2006 |
| Synthesis and stereochemistry of novel [1,2,4]oxadiazolo[4,5‐a][1,5]benzodiazepine derivatives A Chimirri, S Grasso, R Ottanà, G Romeo, M Zappalà Journal of heterocyclic chemistry 27 (2), 371-374, 1990 | 100 | 1990 |
| Chiral 3, 3′-(1, 2-Ethanediyl)-bis [2-(3, 4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling MG Vigorita, R Ottana, F Monforte, R Maccari, MT Monforte, A Trovato, ... Bioorganic & medicinal chemistry 11 (6), 999-1006, 2003 | 93 | 2003 |
| Structure–activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents R Maccari, RM Vitale, R Ottanà, M Rocchiccioli, A Marrazzo, V Cardile, ... European journal of medicinal chemistry 81, 1-14, 2014 | 85 | 2014 |
| In vitro antimycobacterial activities of 2′-monosubstituted isonicotinohydrazides and their cyanoborane adducts R Maccari, R Ottana, F Monforte, MG Vigorita Antimicrobial agents and chemotherapy 46 (2), 294-299, 2002 | 85 | 2002 |
| Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2, 4-thiazolidinediones R Maccari, R Ottanà, R Ciurleo, MG Vigorita, D Rakowitz, T Steindl, ... Bioorganic & medicinal chemistry letters 17 (14), 3886-3893, 2007 | 78 | 2007 |
| In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors R Maccari, A Del Corso, M Giglio, R Moschini, U Mura, R Ottanà Bioorganic & medicinal chemistry letters 21 (1), 200-203, 2011 | 77 | 2011 |
| In vitro advanced antimycobacterial screening of cobalt (II) and copper (II) complexes of fluorinated isonicotinoylhydrazones R Maccari, R Ottanà, B Bottari, E Rotondo, MG Vigorita Bioorganic & medicinal chemistry letters 14 (23), 5731-5733, 2004 | 76 | 2004 |
